Nonalcoholic fatty liver disease (NAFLD) Clinical Trials Database - Free Access to 17 Studies
Access comprehensive clinical trial information for Nonalcoholic fatty liver disease (NAFLD) through Pure Global AI's free database. This collection includes 17 clinical trials across multiple phases including N/A, Not Applicable, Phase 2. Currently, 4 trials are actively recruiting participants.
Research for Nonalcoholic fatty liver disease (NAFLD) is being conducted in Iran, Japan, Bangladesh and 2+ other countries. Leading sponsors include Saiseikai Suita Hospital and Barij Research Center of Medicinal Herbs. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Effects of Vitamin E Delta-tocotrienol supplementation in Nonalcoholic Fatty Liver Disease (NAFLD)
Effect of Omega 3 Fatty Acid supplementation on hepatic steatosis and liver stiffness in patients with nonalcoholic fatty liver disease: a Randomized Controlled Trial
Untitled Trial
Multicenter, prospective research on prevalence and fibrosis stage distribution in Japanese NAFLD patients using with ultrasound elastography [FibroScan] and Fib4 index
Assesment of "Dawa al-Blaghm" on liver enzymes in patients with fatty liver
Effects of exercise on nonalcoholic fatty liver disease
Effects of nutritional education in Non Alcoholic Fatty Liver disease
Effects of the Capparis pickle on Fatty Liver
The effect of olive oil in the treatment of non-alcoholic fatty liver disease
Efficacy and safety of high dose catechin-contained green tea in patients with NAFLD
Diagnostic accuracy of novel scoring systems using serum biomarkers for nonalcoholic steatohepatitis (NASH)
The prospective observational study of incidence rate of hepatic composite event in NAFLD patients
Effect of Purslane seeds in patients with nonalcoholic fatty liver disease
The effect of hepatoheal tablet on non alcoholic fatty liver
Omega 3 on fatty liver
Effect of low caloric diet with and without vitamin D supplementation in non alcoholic fatty liver
A placebo-controlled trial of astaxanthin in subjects with nonalcoholic fatty liver disease
Pure Global AI provides free access to 17 clinical trials studying Nonalcoholic fatty liver disease (NAFLD), aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 5+ countries.
Top research sponsors include Saiseikai Suita Hospital, Barij Research Center of Medicinal Herbs, Department of Hepatology,Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, among others.